AKOYA BIOSCIENCES UK LTD.Active
Key figures
AKOYA BIOSCIENCES UK LTD. does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2024Balance sheet structure
Filed accounts2020–2024
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Turnover | — | 3,179,822 | — | — | — |
| Profit for the year | — | 72,212 | 62,083 | 4,114 | 5,333 |
| Cash at bank and in hand | 60,967 | 52,949 | 224,189 | 105,027 | 128,519 |
| Total assets | 936,940 | 4,332,087 | 9,675,039 | 1,109,266 | 1,227,569 |
| Total liabilities | 800,922 | 4,029,435 | 9,235,107 | 589,344 | 583,608 |
| Net assets / total equity | 136,018 | 302,652 | 446,605 | 527,254 | 655,372 |
| Average number of employees | 15 | 17 | 26 | 29 | 0 |
| Average pay (per year) | — | 110,310 | — | — | — |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: AKOYA BIOSCIENCES UK LTD.
Company
AKOYA BIOSCIENCES UK LTD. is a private limited company registered with Companies House under company number 11611409. It was incorporated on 8 Oct 2018. Its status is active. The registered office is in Bicester (OX26). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2024 (period ending 31 Dec 2024); the company files small company accounts. Profit for the year was £5,333. Net assets were £655,372, up 24.3% on the previous year. Cash at bank and in hand was £128,519. Total assets were £1,227,569 and total liabilities £583,608. The company had an average of 0 employees. Figures are available for 5 financial years (2020–2024).
Control and charges
One person with significant control is registered. 2 of 3 registered charges are outstanding.
Filing deadlines
The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 21 Oct 2026.